Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rituximab Plus Sargramostim vs Rituximab Monotherapy in Relapsed Follicular Lymphoma
NCT00308087Phase 2Terminated
- Sponsor
- Sanofi
- Start
- May 2006
- Primary completion
- Jun 2009
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 2
01
Overview
A Phase 2 trial of sargramostim in follicular lymphoma (FL), sponsored by Sanofi. Started May 2006; status: terminated.
02
Drugs
sargramostim
03
Conditions
follicular lymphoma (FL)
Beyond the preview
Go deeper on NCT00308087.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00308087.